HANGZHOU and SHAOXING, China, March 31, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate...
from PR Newswire: https://ift.tt/3bHzIvL
No comments:
Post a Comment